AnatomyDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceHealth CareGeographicals
Treatment OutcomeClinical Trials as TopicAntineoplastic AgentsDouble-Blind MethodRandomized Controlled Trials as TopicDrug Administration ScheduleAntineoplastic Combined Chemotherapy ProtocolsTime FactorsDisease-Free SurvivalCost-Benefit AnalysisInsurance BenefitsBreast NeoplasmsFollow-Up StudiesAntibodies, Monoclonal, HumanizedNeoplasm MetastasisSurvival AnalysisDeoxycytidineAntibodies, MonoclonalRetrospective StudiesProspective StudiesQuinazolinesDisease ProgressionDrug Therapy, CombinationNeoplasmsKaplan-Meier EstimateAdministration, OralProtein Kinase InhibitorsSurvival RateDrug Resistance, NeoplasmRisk AssessmentAntineoplastic Agents, HormonalDose-Response Relationship, DrugQuality of LifePyrrolesInfusions, IntravenousLung NeoplasmsPlatelet Aggregation InhibitorsImmunotherapyFluorouracilCancer VaccinesTreatment FailureDrug ApprovalBiomarkers, PharmacologicalUnited StatesRecurrencePrognosisPatient SelectionCombined Modality TherapyReceptor, erbB-2Aromatase InhibitorsClinical Trials, Phase II as TopicNeoplasm StagingMelanomaRisk FactorsEndpoint DeterminationMolecular Targeted TherapyAngiogenesis InhibitorsPlacebosClinical Trials, Phase III as TopicClinical Trials, Phase I as TopicChemotherapy, AdjuvantMyocardial InfarctionUnited States Food and Drug AdministrationPilot ProjectsPyrimidinesEvidence-Based MedicineNitrilesCarcinoma, Non-Small-Cell LungTaxoidsTriazolesBenzamidesAnticoagulantsAntimetabolites, AntineoplasticTherapeutic OcclusionPancreatic NeoplasmsTamoxifenCounterpulsationRetreatmentHealth Care CostsIndolesHealth Benefit Plans, EmployeeModels, EconomicNeoplasm Recurrence, LocalSirolimusSeverity of Illness IndexMaximum Tolerated DoseReceptor, Epidermal Growth FactorTiclopidinePiperazinesTumor Markers, BiologicalCohort StudiesHydroxymethylglutaryl-CoA Reductase InhibitorsGastrointestinal Stromal TumorsDecision Support TechniquesAdenocarcinomaAngioplasty, Balloon, CoronaryHeart FailurePaclitaxelDrug CostsStents